186 related articles for article (PubMed ID: 26475334)
1. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
[TBL] [Abstract][Full Text] [Related]
2. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
[TBL] [Abstract][Full Text] [Related]
4. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
5. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
[TBL] [Abstract][Full Text] [Related]
6. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
[TBL] [Abstract][Full Text] [Related]
8. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
[TBL] [Abstract][Full Text] [Related]
9. miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.
Zhang K; Dai L; Zhang B; Xu X; Shi J; Fu L; Chen X; Li J; Bai Y
J Cell Physiol; 2015 Apr; 230(4):903-10. PubMed ID: 25216463
[TBL] [Abstract][Full Text] [Related]
10. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
11. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
[TBL] [Abstract][Full Text] [Related]
13. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
[TBL] [Abstract][Full Text] [Related]
14. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
15. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil.
Przybyła T; Sakowicz-Burkiewicz M; Maciejewska I; Bielarczyk H; Pawełczyk T
Acta Biochim Pol; 2017; 64(2):315-322. PubMed ID: 28510612
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.
Xu WW; Li B; Guan XY; Chung SK; Wang Y; Yip YL; Law SY; Chan KT; Lee NP; Chan KW; Xu LY; Li EM; Tsao SW; He QY; Cheung AL
Nat Commun; 2017 Feb; 8():14399. PubMed ID: 28186102
[TBL] [Abstract][Full Text] [Related]
19. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
20. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.
Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D
J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
